Cryoablation is Your Choice

Freeze your cancer, not your life.

NOW WITH FIRST-IN-CLASS FDA CLEARANCE | ProSense® for the local treatment of low risk breast cancer with endocrine therapy

Cryoablation is Your Choice

Freeze your cancer, not your life.

Choose Breast Cryoablation

Imagine a minimally invasive treatment for breast cancer without the need to remove breast tissue, to undergo general anesthesia, and a lengthy hospital stay. That reality is here with ProSense® Cryoablation by IceCure.

Now with FDA clearance, cryoablation is possible for the local treatment of breast cancer in patients aged 70 and older with biologically low-risk tumors*, less than 1.5 cm in size and who adhere to endocrine therapy.

*Biologically low-risk breast cancer is defined as unifocal tumor, size ≤1.5cm, ER+, PR+, HER2-, Ki-67<15% and/or genomic testing indicative of low-risk breast cancer, infiltrating ductal carcinoma (excluding lobular carcinoma, extensive intraductal component, or evidence of lymphovascular invasion), and clinically negative lymph node (N0).

Breast Cryoablation

What is Breast Cryoablation?

Using extremely low temperatures (lower than –170C°), cryoablation freezes and destroys breast tumors by creating an ice ball around the targeted tissue. Under ultrasound guidance, a small, needle-like cryoprobe is inserted into the tumor and using liquid nitrogen the tumor is frozen. The destroyed tissue naturally reabsorbed by the body over time and adjacent tissue is left unharmed.

Maintain breast shape

Unlike surgery, no tissue is removed,
and there is minimal scarring.

Short, outpatient procedure with minimal recovery time

The average procedure time is between 30 – 45 minutes; patients return to normal activity within median 1 day

Recovery

Local anesthesia & minimal pain

Numbing agents are injected locally into the treatment area; the ice formed during the procedure has a numbing effect

Choose Results with Breast Cancer Cryoablation

Safe &
Effective

5 year-results for the ICE3 clinical study provided evidence to assess the safety and efficacy for the ProSense® cryotherapy treatment of low-risk, early-stage breast cancer with endocrine therapy.

3.1%
Rate of Local Recurrence

Patients treated with cryoablation
and endocrine therapy*

99.1%
Patients

97%
Phycisians

Very satisfied or satisfied
with cosmetic outcome

Choose The Power of Cryoablation to Destroy Tumors

 

Using cryoablation to destroy the tumors by freezing them has been used for decades in clinical practice for the safe and effective ablation of various benign and cancerous tumors.

The ProSense® System has a wide range of clinical applications providing minimally invasive care without the need for surgery or long hospital stays. Learn more about the variety of conditions that can benefit from cryoablation.

†IceCure has regulatory approval worldwide. Please contact us for additional information.

Choose ProSense®
Liquid Nitrogen Technology

Uniquely powered by liquid nitrogen (LN2), the ProSense® Cryoablation System achieves ultra-cold temperatures quickly for tumor destruction.

Rapid & Stable Freezing
Superior Cooling Rate
of LN2
Easy to Use

Easy to operate

Single Cryoprobe Creates
Large Lethal Zone

Easy to Use

Easy to Operate

About Us

IceCure believes in the power of patient choice. We understand that each patient is unique and that they need a diversity of care options to best fit their needs and clinical condition. Cryoablation empowers patients with a choice that can help turn a daunting experience in the fight against cancer, into a hopeful and restorative one.

IceCure aims to set an alternative for women’s health and interventional oncology. By providing outstanding results with a minimally invasive, convenient, and comfortable  experience, our ProSense® Cryoablation System delivers on this promise. 


It’s Your Choice.